Joel Sendek

Joel Sendek currently serves as the Chief Financial Officer at Perspective Therapeutics, a position held since September 2025. Prior to this role, Joel held various senior positions in finance and research, including Managing Director and Head of Healthcare Life Sciences Research at Oppenheimer & Co. Inc. from August 2022 to September 2025, and Chief Financial Officer at Dewpoint Therapeutics, Sema4, Spero Therapeutics, and Forward Pharma A/S during the years spanning from 2014 to 2022. Earlier career experiences include managing roles at Stifel Financial Corp. and Lazard, as well as serving as an Analyst at Gerard Klauer Mattison and Director of Corporate Development at Progenics Pharmaceuticals. Joel Sendek earned a Bachelor of Arts degree in Biochemistry from Rice University, graduating in 1989.